The Precision Peptide Company Inc. BPC
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.16M | -4.35M | -4.16M | -3.29M | -1.19M |
| Total Depreciation and Amortization | 33.30K | 66.00K | 66.00K | 66.00K | 34.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.73M | 2.28M | 2.24M | 1.68M | 65.00K |
| Change in Net Operating Assets | -1.02M | -461.10K | -377.00K | -401.40K | 125.10K |
| Cash from Operations | -3.42M | -2.47M | -2.23M | -1.94M | -966.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 379.60K | 261.50K | 151.10K | 99.90K | -190.10K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -72.80K | -72.80K | -72.80K | -72.80K |
| Cash from Investing | 379.60K | 188.70K | 78.30K | 27.10K | -262.90K |
| Total Debt Issued | 100.00K | 100.00K | 96.60K | 100.00K | 17.80K |
| Total Debt Repaid | -17.80K | -18.80K | -35.70K | -35.70K | -17.90K |
| Issuance of Common Stock | 4.15M | 1.50M | 946.00K | 1.18M | 1.30M |
| Repurchase of Common Stock | -- | -475.00K | -475.00K | -475.00K | -475.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.00K | 2.72M | 2.72M | 2.72M | 2.72M |
| Cash from Financing | 3.06M | 2.79M | 2.35M | 2.51M | 2.55M |
| Foreign Exchange rate Adjustments | -66.50K | -37.80K | -32.90K | 5.90K | -5.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 14.90K |
| Net Change in Cash | -50.30K | 467.80K | 159.00K | 603.00K | 1.33M |